Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505284 · ClinicalTrials.gov registry record · Phase 2
An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy
A Phase 2 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 2
- Development phase
- 352
- Enrollment target
NCT00505284: Completed Phase 2 study, sponsored by Eisai.
NCT00505284 is a Phase 2 study that has completed, run by Eisai. The registered enrollment target is 352 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (165% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00505284, a Phase 2 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 352 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
Primary Outcome
Average of last 7 available scores prior to the visit, based on 11-point Likert-type numerical rating scale for pain (0=no pain, to 10=worst possible pain). This is based on a modified baseline observation carried forward (BOCF).
Interventions
- DRUG Placebo
- DRUG E2007 (2 mg)
- DRUG E2007 (4 mg)
- DRUG E2007 (6 mg)
- DRUG E2007 (8 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
What the finished NCT00505284 record still lists
NCT00505284 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (165% higher).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00505284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00505284 about?
NCT00505284 is a clinical study titled "An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy". The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
What is the current status of trial NCT00505284?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 352 participants. The study started on 2007-06. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00505284?
The interventions under investigation include: Placebo (DRUG), E2007 (2 mg) (DRUG), E2007 (4 mg) (DRUG), E2007 (6 mg) (DRUG), E2007 (8 mg) (DRUG).
Who is sponsoring clinical trial NCT00505284?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00505284's enrollment target sits among peer trials
352 130th of 2000 higher than 1,871 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05811936 · 352 participants · NA
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
- NCT06258941 · 352 participants · Phase 1
Classroom Break, Cognition, and Fitness in Elementary School Children
- NCT06269081 · 352 participants · NA
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
- NCT06337292 · 352 participants · Phase 3
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia